U.S. FDA OKs Pfizer COVID-19 booster for children ages 12 to 15

Click to play video: 'What happens when parents and kids disagree on COVID-19 vaccines'
What happens when parents and kids disagree on COVID-19 vaccines
WATCH: What happens when parents and kids disagree on COVID-19 vaccines – Dec 10, 2021

The U.S. Food and Drug Administration on Monday authorized the use of a third dose of the Pfizer and BioNTech COVID-19 vaccine for children aged between 12 and 15 years, and narrowed the time for all booster shots to five months from six months after primary doses.

The agency also authorized a third shot in children aged five through 11 years who are immunocompromised.

Read more: COVID-19 vaccines for kids: What Canadian parents should know

Read next: U.S. shoots down suspected Chinese spy balloon over Atlantic ocean

The FDA said it reviewed published data and real world evidence on the safety of booster doses provided by the Israeli Ministry of Health including data from over 6,300 individuals 12-to-15 years of age who received a Pfizer shot.

Global COVID-19 cases are surging due to the Omicron variant and health authorities have warned that its extremely high transmissibility could overwhelm many health systems.

Story continues below advertisement

Read more: Pfizer COVID-19 vaccine causes mostly mild side effects in kids: CDC

Read next: This gibbon became pregnant while living in isolation. How is that possible?

Laboratory tests have shown that two doses of the Pfizer-BioNTech and Moderna vaccines generate low immune responses against Omicron, while boosters appear to be protective against the highly-mutated variant.

Sponsored content